Hepatitis C virus E2 and NS5A region variability during sequential treatment with two interferon-? preparations
- 4 March 2003
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 70 (1), 62-73
- https://doi.org/10.1002/jmv.10351
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Mutations that permit efficient replication of hepatitis C virus RNA in Huh-7 cells prevent productive replication in chimpanzeesProceedings of the National Academy of Sciences, 2002
- New therapeutic strategies for hepatitis CHepatology, 2002
- Efficient Initiation of HCV RNA Replication in Cell CultureScience, 2000
- Long term response to interferon treatment in chronic hepatitis C patients is associated with a significant reduction in anti-E1 envelope antibody titersJournal of Medical Virology, 1999
- Mutations in the NS5A region do not predict interferon-responsiveness in American patients infected with genotype 1b hepatitis C virusJournal of Medical Virology, 1999
- Sequence analysis of the NS5A protein of European hepatitis C virus 1b isolates and relation to interferon sensitivity.Journal of General Virology, 1998
- Comparison of the rate of sequence variation in the hypervariable region of E2/NS1 region of hepatitis C virus in normal and hypogammaglobulinemic patientsHepatology, 1998
- Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus.Journal of Clinical Investigation, 1997
- Pretreatment Virus Load and Multiple Amino Acid Substitutions in the Interferon Sensitivity-Determining Region Predict the Outcome of Interferon Treatment in Patients With Chronic Genotype 1B Hepatitis C Virus InfectionHepatology, 1997
- Effect of Recombinant or Lymphoblastoid Interferon-α on Alanine Aminotransferase in Patients with Chronic Hepatitis C or Chronic Non-A Non-B HepatitisClinical Drug Investigation, 1995